Farmacéuticos Comunitarios Vol. 14 Nº 3 | Farmacéuticos Comunitarios

1 July 2022
Vol. 14 N.3

Editorial

A necessary, safe and effective guide Bellver O.

Originals

A qualitative study of barriers and facilitators in the demand for Community Pharmacy Services in Spanish community pharmacies Qart-Fernández I, Bermejo M, González-Álvarez M, Melero-Zaera A, Mud-Castelló F, Baixauli-Fernández VJ.
Adverse effects of SARS-CoV-2 vaccines in community pharmacists from Pontevedra Andrés-Rodríguez NF, Fornos-Pérez JA, Busto-Domínguez I, Mera-Gallego R, García-Rodríguez P, Carrera-Pérez-de-Juan MD, León-Rodríguez L, Mera-Gallego I, Acuña-Ferradanes A.
Results of the implementation of a multidisciplinary smoking cessation program combining varenicline and behavioural therapy in a community pharmacy Bonilla A, Cavada MA.
Approach to symptoms of diarrhea and constipation by the community pharmacist in the period of a COVID-19 pandemic: an observational, cross-sectional and multicenter study Gómez-Martínez J, Rey E, Ciriza C, Dávila D, Turbí C.

Case Reports

Personalized dosification systems (pds), beyond the blister: presentation of a clinical case in a patient with Alzheimer’s disease García-Delgado A, García-Delgado M.
Importance of the medication reconciliation service in the community pharmacy Arasanz D.

-

Manual for authors

Last update of farmaceuticoscomunitarios.org : 03.02.2023

Copyright © (Sociedad Española de Farmacia Clínica, Familiar y Comunitaria) |
ISSN Digital edition: 2173-9218
Journal committees - Legal notice - Privacy policy - Cookies policy - Advertising policy

e-mail: soporte@sefac.org | Responsible for this web site: Jordi Serrano Valdés

Development, Web design & computer programming: Edittec |

The information provided on this site is intended to complement and not to replace the

relation between a patient and his or her existing physician.